Annual CFF
$479.70 M
+$360.01 M+300.78%
December 31, 2023
Summary
- As of February 8, 2025, MLTX annual cash flow from financing activities is $479.70 million, with the most recent change of +$360.01 million (+300.78%) on December 31, 2023.
- MLTX annual CFF is now at all-time high.
Performance
MLTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$183.10 K
+$183.10 K+100.00%
September 30, 2024
Summary
- As of February 8, 2025, MLTX quarterly cash flow from financing activities is $183.10 thousand, with the most recent change of +$183.10 thousand (+100.00%) on September 30, 2024.
- Over the past year, MLTX quarterly CFF has increased by +$183.10 thousand (+100.00%).
- MLTX quarterly CFF is now -99.96% below its all-time high of $451.29 million, reached on June 30, 2023.
Performance
MLTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$79.58 M
+$183.10 K+0.23%
September 30, 2024
Summary
- As of February 8, 2025, MLTX TTM cash flow from financing activities is $79.58 million, with the most recent change of +$183.10 thousand (+0.23%) on September 30, 2024.
- Over the past year, MLTX TTM CFF has increased by +$183.10 thousand (+0.23%).
- MLTX TTM CFF is now -85.00% below its all-time high of $530.68 million, reached on March 31, 2024.
Performance
MLTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MLTX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +300.8% | +100.0% | +0.2% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
MLTX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +300.8% | -100.0% | -100.0% | -85.0% | +430.4% |
| 5 y | 5-year | at high | +300.8% | -100.0% | -100.0% | -85.0% | +430.4% |
| alltime | all time | at high | +300.8% | -100.0% | -100.0% | -85.0% | +430.4% |
MoonLake Immunotherapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $183.10 K(>+9900.0%) | $79.58 M(+0.2%) |
| Jun 2024 | - | $0.00(-100.0%) | $79.39 M(-85.0%) |
| Mar 2024 | - | $50.98 M(+79.4%) | $530.68 M(+10.6%) |
| Dec 2023 | $479.70 M | $28.42 M(>+9900.0%) | $479.70 M(+6.3%) |
| Sep 2023 | - | $0.00(-100.0%) | $451.29 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $451.29 M(>+9900.0%) | $451.29 M(+331.1%) |
| Mar 2023 | - | $0.00(-100.0%) | $104.69 M(-12.5%) |
| Dec 2022 | $119.69 M | $3800.00(>+9900.0%) | $119.69 M(+0.0%) |
| Sep 2022 | - | $0.00(-100.0%) | $119.69 M(0.0%) |
| Jun 2022 | - | $104.69 M(+597.7%) | $119.69 M(+697.7%) |
| Mar 2022 | - | $15.00 M | $15.00 M |
FAQ
- What is MoonLake Immunotherapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual CFF year-on-year change?
- What is MoonLake Immunotherapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly CFF year-on-year change?
- What is MoonLake Immunotherapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM CFF year-on-year change?
What is MoonLake Immunotherapeutics annual cash flow from financing activities?
The current annual CFF of MLTX is $479.70 M
What is the all time high annual CFF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual cash flow from financing activities is $479.70 M
What is MoonLake Immunotherapeutics annual CFF year-on-year change?
Over the past year, MLTX annual cash flow from financing activities has changed by +$360.01 M (+300.78%)
What is MoonLake Immunotherapeutics quarterly cash flow from financing activities?
The current quarterly CFF of MLTX is $183.10 K
What is the all time high quarterly CFF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly cash flow from financing activities is $451.29 M
What is MoonLake Immunotherapeutics quarterly CFF year-on-year change?
Over the past year, MLTX quarterly cash flow from financing activities has changed by +$183.10 K (+100.00%)
What is MoonLake Immunotherapeutics TTM cash flow from financing activities?
The current TTM CFF of MLTX is $79.58 M
What is the all time high TTM CFF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM cash flow from financing activities is $530.68 M
What is MoonLake Immunotherapeutics TTM CFF year-on-year change?
Over the past year, MLTX TTM cash flow from financing activities has changed by +$183.10 K (+0.23%)